top of page

Invega Extended-Release Tablet 3mg

Product details

Registration number: SIN13380P

Classification: Prescription Only

Active ingredients: Paliperidone

Strength: 3mg

Dosage form: TABLET, EXTENDED RELEASE

Route: ORAL

Registrant: JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD

ATC code: N05AX13

HSA approval date: 7 December 2007

Manufacturer(s): JANSSEN CILAG MANUFACTURING LLC

Manufacturing country/countries: PUERTO RICO

What are the HSA registration number and classification for Invega Extended-Release Tablet 3mg?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN13380P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for Invega Extended-Release Tablet 3mg?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Paliperidone

Strength: 3mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for Invega Extended-Release Tablet 3mg?

According to the HSA dataset updated 7 August 2026:

Dosage form: TABLET, EXTENDED RELEASE

Route: ORAL

Source for this answer

Who is the recorded registrant for Invega Extended-Release Tablet 3mg?

According to the HSA dataset updated 7 August 2026:

Registrant: JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD

Source for this answer

Which manufacturers and countries are listed for Invega Extended-Release Tablet 3mg?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): JANSSEN CILAG MANUFACTURING LLC

Manufacturing country/countries: PUERTO RICO

Source for this answer

Where can I look up Invega Extended-Release Tablet 3mg in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN13380P or the exact product name Invega Extended-Release Tablet 3mg. The general register link does not preselect this product.

Source for this answer

What are the source dates for this Invega Extended-Release Tablet 3mg record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this Invega Extended-Release Tablet 3mg record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN13380P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page